Prosetta

Prosetta Biosciences, Inc. is a 12-year old biotechnology company developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS) by scientists at the University of California, San Francisco and the University of Washington, Seattle. The incorporation of the CFPSS in our drug discovery platform, has lead to the identification of small molecules which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids (the protein shell that protects the DNA or RNA genome of a virus). Prosetta has successfully produced highly potent compounds which display activity against multiple strains of many viral families including lead series of molecules that are effective antiviral agents against Influenza, HIV and HCV.
Type
Private
HQ
San Francisco, US
Employees
45 (est)
Prosetta has headquartered in San Francisco, US

Prosetta Locations

San Francisco, US

Prosetta Metrics

Prosetta Summary

Total Funding

$2 M

Latest funding size

$2 M

Time since last funding

over 9 years
Prosetta's latest funding round of $2 M was in May 2007. In total, Prosetta has raised $2 M.

Prosetta Company Life

You may also be interested in